Neurologic Complications in Patients With Lymphoreticular Malignancy: A Descriptive Cohort Study

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Hematology

Background:

• Lymphoreticular malignancy in children presents unique challenges.
• Neurologic complications can arise at diagnosis and during treatment.
• Understanding these complications is crucial for patient management.

Purpose of the Study:

• To investigate the spectrum of neurologic complications in pediatric patients with lymphoreticular malignancy.
• To determine the causes of these neurologic complications.
• To assess outcomes and management strategies.

Main Methods:

• A descriptive cohort study involving 204 children with lymphoreticular malignancy.
• Baseline investigations and evaluations for neurologic symptoms, including cerebrospinal fluid examination, radiologic, and electrophysiologic studies.
• Management followed standard guidelines.

Main Results:

• 14.7% of patients (30/204) developed neurologic complications, predominantly during chemotherapy (87%).
• Common complications included methotrexate neurotoxicity (7), vincristine neurotoxicity (7), and central nervous system (CNS) relapse (4).
• 70% of complications resolved with treatment, while 6.7% persisted; 13.3% of patients expired.

Conclusions:

• Neurologic complications in pediatric lymphoreticular malignancy are diverse, with varied presentations.
• Close monitoring and effective interventions are key to reducing morbidity and mortality.
• Early detection and management are vital for improving outcomes in affected children.